Faculty profile

Maxwell Sauder

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Toronto

Maxwell Sauder

Assistant Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
19 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials
British Journal of Dermatology · 2026
Glucagon-like peptide-1 receptor agonists as metabolic adjuncts in immune-mediated skin disease.
Journal of the American Academy of Dermatology · 2026
Massive Solitary Liver Metastasis From a Locally Recurrent Basal Cell Carcinoma Treated With Stereotactic Body Radiation Therapy: A Rare Manifestation of a Common Disease.
Advances in radiation oncology · 2026

All 19 publications

19 publications.

Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials

Gold LS, Armstrong AW, Soung J, Vender RB, Cantero ÁG, Hoffmann M, Guenthner ST, Hong HC-H, Murrell DF, Song EJ

British Journal of Dermatology20262 citationsOpen Access

DOI: 10.1093/bjd/ljag264

Glucagon-like peptide-1 receptor agonists as metabolic adjuncts in immune-mediated skin disease.

Lazarowitz R, Saroufim L, Sauder M, Osman M, Tardio V, Litvinov IV, Netchiporouk E

Journal of the American Academy of Dermatology2026

DOI: 10.1016/j.jaad.2026.02.047 PMID: 41713583

Massive Solitary Liver Metastasis From a Locally Recurrent Basal Cell Carcinoma Treated With Stereotactic Body Radiation Therapy: A Rare Manifestation of a Common Disease.

Gerard IJ, Butler M, Martinez EA, Sauder M, Kim TK, Faye MD, Glynn AM, Kamil ZS, Dawson LA

Advances in radiation oncology2026Open Access

DOI: 10.1016/j.adro.2026.102035 PMID: 42306309

A Response to the Letter to the Editor: "Comment on COCOON: Daily 4% Chlorhexidine for Nail Care-Rationale, Safety, and Evidence Gaps".

Cho BC, Sauder M, Simoes J, Girard N

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2026

DOI: 10.1016/j.jtho.2025.12.005 PMID: 41651576

MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids.

Wong HCY, Lee SF, Wolf JR, van den Hurk C, Chan RJ, Sauder M, Kwan JYY, Aquilano M, Tse SSW, Marta GN, Chow E, Bonomo P

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

DOI: 10.1007/s00520-026-10659-1 PMID: 41973254

Metformin as a Senomorphic Adjunct in Immune-Mediated Dermatoses.

Lazarowitz R, Saroufim L, Sauder M, Osman M, Tardio V, Litvinov IV, Netchiporouk E

Journal of the American Academy of Dermatology2026

DOI: 10.1016/j.jaad.2026.08.128 PMID: 42800562

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.

Legat FJ, Kwatra SG, Reich A, Boulinguez S, Tsianakas A, Sauder M, Barbarot S, Szepietowski JC, Conrad C, Pink AE, Weisshaar E, Misery L, Metz M, Laquer VT, Sivamani RK, Yosipovitch G, Thaçi D, Skov L, Chen X, Noda A, Jabbar-Lopez ZK, Piketty C, Ständer S

Journal of the European Academy of Dermatology and Venereology : JEADV2026

DOI: 10.1111/jdv.70266 PMID: 41405008

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Adam SR, Sauder M

Skin therapy letter2026Senior author

PMID: 42202148

A Review of Post-Inflammatory Pigmentation Changes: Pathophysiology, Diagnosis and Treatment.

Yadav G, Sauder M, Siddha S, Zeinab R, Barakat M, Joseph M

Journal of cutaneous medicine and surgery2026

DOI: 10.1177/12034754261427395 PMID: 41847987

Modified Delphi Consensus on Interventions for Acute Radiation Dermatitis in Breast Cancer: A Canadian Expert Perspective

Cao JQ, Yassa M, Bolivar CHA, Dahn H, Kong I, Logie N, Théberge V, Wiebe E, Caudrelier J-M, Bourque J-M

International Journal of Radiation Oncology Biology Physics20258 citations

DOI: 10.1016/j.ijrobp.2024.12.037

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Maxwell Sauder

Research

Latest papers

Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials

Glucagon-like peptide-1 receptor agonists as metabolic adjuncts in immune-mediated skin disease.

Massive Solitary Liver Metastasis From a Locally Recurrent Basal Cell Carcinoma Treated With Stereotactic Body Radiation Therapy: A Rare Manifestation of a Common Disease.

A Response to the Letter to the Editor: "Comment on COCOON: Daily 4% Chlorhexidine for Nail Care-Rationale, Safety, and Evidence Gaps".

MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids.

Metformin as a Senomorphic Adjunct in Immune-Mediated Dermatoses.

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

A Review of Post-Inflammatory Pigmentation Changes: Pathophysiology, Diagnosis and Treatment.

Modified Delphi Consensus on Interventions for Acute Radiation Dermatitis in Breast Cancer: A Canadian Expert Perspective

Frequent collaborators

Geeta Yadav

Marissa Joseph

Edward Chow

Marcus Butler

Ronald Vender

Jensen Yeung

Rebecca Levy

Jean-Marc Bourque

Iwa Kong

Jean-Michel Caudrelier

Jaggi Rao

Yvette Miller-Monthrope

Mohammed Osman

Ivan Litvinov

Elena Netchiporouk

Danielle Rodin

Maxwell Sauder

Research

Latest papers

Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials

Glucagon-like peptide-1 receptor agonists as metabolic adjuncts in immune-mediated skin disease.

Massive Solitary Liver Metastasis From a Locally Recurrent Basal Cell Carcinoma Treated With Stereotactic Body Radiation Therapy: A Rare Manifestation of a Common Disease.

A Response to the Letter to the Editor: "Comment on COCOON: Daily 4% Chlorhexidine for Nail Care-Rationale, Safety, and Evidence Gaps".

MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids.

Metformin as a Senomorphic Adjunct in Immune-Mediated Dermatoses.

Nemolizumab in prurigo nodularis up to 100&#x2009;weeks: OLYMPIA LTE interim analysis.

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

A Review of Post-Inflammatory Pigmentation Changes: Pathophysiology, Diagnosis and Treatment.

Modified Delphi Consensus on Interventions for Acute Radiation Dermatitis in Breast Cancer: A Canadian Expert Perspective

Frequent collaborators

Geeta Yadav

Marissa Joseph

Edward Chow

Marcus Butler

Ronald Vender

Jensen Yeung

Rebecca Levy

Jean-Marc Bourque

Iwa Kong

Jean-Michel Caudrelier

Jaggi Rao

Yvette Miller-Monthrope

Mohammed Osman

Ivan Litvinov

Elena Netchiporouk

Danielle Rodin

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.